TFRC and ovarian carcinoma: In summary, this study reveals a novel mechanism by which VISTA+ Tfr cells contribute to immune escape in ovarian cancer through multi-dimensional regulation of effector immune cell functions, providing new perspectives for understanding the complexity of the tumor immune microenvironment.